Paul Mintz

Paul Mintz

Directeur/Membre du Conseil chez NUO THERAPEUTICS, INC.

Fortune : 107 211 $ au 31/05/2026

77 ans
Health Technology
Consumer Services
Health Services

Profil

Paul D.
Mintz
currently serves as Independent Director at Nuo Therapeutics, Inc. since 2017 and as Chief Medical Officer & Senior Vice President at Verax Biomedical, Inc. since 2016.
Formerly, Dr. Mintz was Director at Immucor, Inc. from 2009 to 2011, Chief-Clinical Pathology & Medical Director at University of Virginia Health System from 1979 to 2011, Director-Hematology Clinical Review Division at US Food & Drug Administration from 2011 to 2016, President of the American Association of Blood Banks from 2004 to 2005, and Professor-Pathology & Internal Medicine at The University of Virginia School of Medicine from 1979 to 2011.
Other former roles include Director at Clinical Pathology Laboratories, Inc., Co-Medical Director at Virginia Blood Services, and Trustee at National Blood Foundation.
Education includes undergraduate studies at Rochester Christian University and a doctorate from the University of Rochester Medical Center.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/12/2025 108 294 ( 0,22% ) 107 211 $ 31/05/2026

Postes actifs de Paul Mintz

SociétésPosteDébut
NUO THERAPEUTICS, INC. Directeur/Membre du Conseil 07/04/2017
Directeur Technique/Scientifique/R&D 01/01/2016

Anciens postes connus de Paul Mintz

SociétésPosteFin
Corporate Officer/Principal 01/01/2016
Corporate Officer/Principal 01/02/2011
Corporate Officer/Principal 01/02/2011
IMMUCOR, INC. Directeur/Membre du Conseil 01/01/2011
President 01/01/2005
Voir l'expérience en détail de Paul Mintz

Formation de Paul Mintz

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

30

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Services

Health Services

Government

Consumer Services

National Blood Foundation

Health Services

Consumer Services

  1. Bourse
  2. Insiders
  3. Paul Mintz
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT